Literature DB >> 21251947

Disrupting effects of bifenthrin on ovulatory gene expression and prostaglandin synthesis in rat ovarian granulosa cells.

Jing Liu1, Ye Yang, Yan Yang, Ying Zhang, Weiping Liu.   

Abstract

Synthetic pyrethroids (SPs) are one of the most frequently and widely used classes of pesticides. Although exposure to SPs is associated with reproductive toxicity in mammals, limited information is available regarding the effects of SPs on female ovulatory function. Bifenthrin (BF), a broad-spectrum type I SP, has been widely used for pest control for two decades. Previous studies showed that BF had estrogen-like activity as an endocrine-disrupting chemical. In this work, we showed the in vitro inhibitory effects of BF on luteinizing hormone (LH)-inducible ovulatory gene expression in rat ovarian granulosa cells, including genes P450scc, StAR, PR, AREG, EREG, TGF-β1, C/EBP β, RUNX1, p21, cyclin E1, CYP19a1, SULT1E1 and PTGS2. Our in vivo studies demonstrated that short-term administration of BF to gonadotropin-primed rats disrupted the expression of LH-responsible ovulatory genes, suggesting that BF has similar disrupting effects on in vitro and in vivo LH signaling. Because prostaglandins and their key synthetic enzyme PTGS2 play pivotal roles in ovulatory process, we further investigated the molecular mechanism of disruption of PTGS2 by BF. Importantly, we found that BF blocked LH-inducible prostaglandin E2 (PGE2) accumulation in cultured medium of granulosa cells. Forskolin stimulated PTGS2 expression was decreased by treatment with BF, indicating that BF may inhibit LH-induced PTGS2 expression through the protein kinase A (PKA)-mediated signaling pathway. In addition, the reduction in transcriptional activity of forskolin-stimulated PTGS2 promoter by BF, indicates that BF blocks the expression of PTGS2 gene at the transcriptional level. Taken together, our present study firstly shows the systemic disrupting effects of BF on the network of ovulatory gene expression patterns as well as prostaglandin synthesis, and suggest that exposure to BF may increase the risk of ovulatory dysfunction in females.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251947     DOI: 10.1016/j.tox.2011.01.007

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

1.  Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa.

Authors:  Kristina W Whitworth; Donna D Baird; Anne Z Steiner; Riana M S Bornman; Gregory S Travlos; Ralph E Wilson; Matthew P Longnecker
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

Review 2.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

3.  Hormonal induction of polo-like kinases (Plks) and impact of Plk2 on cell cycle progression in the rat ovary.

Authors:  Feixue Li; Misung Jo; Thomas E Curry; Jing Liu
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

4.  Microbial detoxification of bifenthrin by a novel yeast and its potential for contaminated soils treatment.

Authors:  Shaohua Chen; Jianjun Luo; Meiying Hu; Peng Geng; Yanbo Zhang
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

5.  Diazinon Interrupts Ovarian Steroidogenic Acute Regulatory (StAR) Gene Transcription in Gonadotropin-Stimulated Rat Model.

Authors:  Asma Siavashpour; Younes Ghasemi; Bahman Khalvati; Fereshteh Jeivad; Negar Azarpira; Hossein Niknahad
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

6.  Low concentrations of o,p'-DDT inhibit gene expression and prostaglandin synthesis by estrogen receptor-independent mechanism in rat ovarian cells.

Authors:  Jing Liu; Meirong Zhao; Shulin Zhuang; Yan Yang; Ye Yang; Weiping Liu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.